THE ANABOLICPROTOCOL
MedicationsHigh risk

Insulin

Also known as: Insulin, Humalog, Novorapid, Lantus, Humulin, Insulin Aspart, Insulin Lispro, Insulin Glargin

The only substance in bodybuilding that can kill within hours of a single dosing error — and the one where the error is easiest to make.

Substance family

Cardiovascular & metabolic agents

Medications for blood pressure, lipids and glucose. They appear here because these are exactly the markers most anabolic compounds push in the wrong direction.

Effects on

Which outcomes this substance acts on — descriptive, not a recommendation.

Strain profile

Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.

Liver
minimal
Kidneys
low
Blood lipids
low
Hematocrit
minimal
Blood pressure
minimal
Hormonal axis
minimal

This substance causes

Dosing & protocols by goal

Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.

Diabetes (approved indication)

Medical

Dose

Individually titrated to blood glucose

Frequency

Per medical regimen

Cycle length

Ongoing, medically supervised

In diabetes, insulin replaces something the body cannot produce, dosed against measured glucose. Every use described below adds insulin to a body that already makes its own.

Doses reported in bodybuilding — 2–5 IU

Not a recommendation

Dose

2–5 IU rapid-acting, post-workout

Frequency

Varies

Cycle length

Described as the 'cautious' range, and requiring roughly 20–50 g of carbohydrate to cover at the widely cited 10 g per IU rule. Severe hypoglycaemia has still occurred at these amounts — the response depends on body weight, insulin sensitivity, carbohydrate intake and the training just completed, and those vary day to day in the same person.

Doses reported in bodybuilding — 10 IU and above

Not a recommendation

Dose

10+ IU

Frequency

Varies

Cycle length

At the same rule of thumb this needs 100 g of carbohydrate or more, spread across the full duration of action rather than eaten once. This is the range in which documented deaths and permanent brain damage occurred. There is no dose established as safe outside a diabetes regimen with glucose monitoring.

Supraphysiological doses carry significant health risks and are not legal without a medical indication. This information serves education and harm reduction, not as a usage recommendation. Accompanying blood work and — where relevant — a post-cycle plan (PCT) are essential. See the disclaimer.

Side effect & countermeasure

Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.

Problem

Hypoglycaemia — it can kill within hours

Countermeasure

This is not a side effect to manage; it is the primary risk. Blood glucose falling too far causes confusion, seizures, unconsciousness and death, and the brain damage from a prolonged episode is permanent. Fast-acting carbohydrate must be within reach before the injection, not fetched afterwards. Someone else should know what was taken and be able to call emergency services.

Problem

Falling asleep after injecting

Countermeasure

A recurring pattern in fatal cases. Sleeping through the peak means the warning symptoms — sweating, trembling, confusion — go unnoticed. Never inject before sleeping, and never inject alone.

Problem

The same dose behaves differently on different days

Countermeasure

Insulin sensitivity varies with training, sleep, carbohydrate intake, alcohol and body composition. A dose tolerated last week can cause severe hypoglycaemia today. There is no dose that is reliably safe because the variable is not the dose alone.

Problem

Beta blockers mask the warning signs

Countermeasure

The early symptoms of low blood sugar — trembling, palpitations — are adrenergic. Beta blockers such as nebivolol suppress exactly those. The combination removes the warning while leaving the danger.

Problem

Confusing insulin types

Countermeasure

Rapid-acting analogues peak within an hour or two; long-acting types act over more than a day. Mixing them up, or dosing a long-acting insulin as if it were rapid, produces an episode that cannot be waited out.

Problem

Increased fat gain alongside muscle

Countermeasure

Insulin promotes storage in all tissues, not just muscle. The body composition outcome depends entirely on training and food, and it frequently goes in the wrong direction.

Overview

Insulin belongs on this site because it is used in bodybuilding, and because someone considering it should encounter accurate information rather than forum confidence.

It also needs stating plainly at the start: apart from DNP, this is the most dangerous substance covered here. Not because of long-term organ damage — because a single miscalculation can be fatal the same day.

Mechanism of Action

Insulin moves glucose and amino acids from the blood into cells. In muscle that means glycogen storage and improved amino acid uptake, which is the anabolic effect it is used for. That effect is real and well understood.

The danger comes from the same mechanism working too well. If insulin moves more glucose out of the blood than is available to replace it, blood glucose falls. The brain has no glucose reserve and depends on a continuous supply. Below a certain point comes confusion, then seizures, then unconsciousness. A prolonged episode causes permanent brain damage, and a severe one causes death.

This can happen within an hour of the injection.

In diabetes, insulin replaces a hormone the body cannot produce, dosed against measured blood glucose with medical oversight. Every use described in a bodybuilding context adds insulin to a body that already produces its own — which is a fundamentally different situation, and the reason no dose from the medical setting transfers.

Why the Dosing Question Cannot Be Answered

For most substances on this site, a lower range is meaningfully safer than a higher one. With insulin, that framing breaks down, and it is worth being precise about why.

The response to a given dose is not determined by the dose alone. It depends on body weight, current insulin sensitivity, how many carbohydrates were eaten and when, how hard the training session was, sleep, alcohol, and where in the cycle of other compounds someone is. Those variables shift day to day within the same person.

That is why documented severe hypoglycaemia exists at amounts described in forums as beginner-level. The dose that was fine last Tuesday is not automatically fine today, and there is no way to know in advance which day is which.

A second pattern runs through the fatal cases: injecting and then sleeping. Sleep removes the ability to notice the early warning signs — sweating, trembling, confusion — which are the only thing standing between a manageable episode and an unsurvivable one.

The Numbers That Actually Matter

The dose in IU is the number people ask about. It is not the number that decides whether someone survives the afternoon. These are:

Carbohydrate per unit

The rule that circulates in this context is roughly 10 g of carbohydrate per 1 IU of rapid-acting insulin. In clinical diabetes care the equivalent figure — the insulin-to-carbohydrate ratio — is individually determined and often sits between 10 and 15 g per unit, so 10 g is the more conservative end.

It is a starting estimate, not a guarantee. Insulin sensitivity after a hard training session can be substantially higher than at rest, which means the same 10 g per unit that worked yesterday can be insufficient today. The rule tells you the minimum ballpark to have available. It does not tell you that you are safe.

Two practical consequences that get missed:

  • The carbohydrate must be spread across the full duration of action, not eaten once at the start. A single large meal covers the first hour or two; the drop that catches people comes in hour three or four when the meal is gone and the insulin is not.
  • Protein and fat do not count. Only carbohydrate raises blood glucose fast enough to matter here.

Duration of action by insulin type

Confusing these is one of the recurring fatal patterns, and the profiles are not similar:

TypeOnsetPeakTotal duration
Rapid-acting analogue (lispro / Humalog, aspart / Novorapid, glulisine / Apidra)10–20 min1–2 h3–5 h
Regular / short-acting (Humulin R, Actrapid)~30 min2–4 h6–8 h
Intermediate NPH (Humulin N, Insulatard)1–2 h4–8 h12–18 h
Long-acting (glargine / Lantus, detemir / Levemir, degludec / Tresiba)1–2 hno pronounced peak20–24 h (Tresiba up to 42 h)

The last row is the one to understand properly. A hypoglycaemic episode under a long-acting insulin cannot be eaten through and cannot be waited out — it lasts as long as the insulin does, which is the better part of a day. Long-acting insulin taken as if it were rapid-acting is not a recoverable mistake at home.

Blood glucose thresholds

Measured with a meter, not estimated:

  • 70–99 mg/dl (3.9–5.5 mmol/l) — normal fasting range
  • Below 70 mg/dl (3.9 mmol/l) — hypoglycaemia. Act now, do not wait to see whether it settles
  • Below 54 mg/dl (3.0 mmol/l) — clinically severe; judgement is already impaired at this point, which is exactly why the decision must not depend on how you feel
  • Below roughly 40 mg/dl (2.2 mmol/l) — the range in which unconsciousness and seizures occur

Treating a low: the 15-15 rule

The standard medical protocol is 15–20 g of fast carbohydrate, wait 15 minutes, measure again, repeat if still below 70 mg/dl.

Two adjustments for this context. First, the doses used here are typically larger than a diabetic correction, so 15 g will often not be enough — the amount needed scales with the insulin still active. Second, the reading coming back up does not mean it is over: the insulin is still working, and a second drop is common. Eating a slower carbohydrate source afterwards, and staying awake and monitored for the remaining duration of action, is the part people skip.

15 g of fast carbohydrate is roughly: 150 ml of fruit juice or regular soft drink, 3–4 glucose tablets, or a tablespoon of honey or sugar. Chocolate is a poor choice — the fat slows absorption exactly when speed is the point.

If Someone Is Using It Anyway

The following reduces risk without making it acceptable:

  • Fast-acting carbohydrate within arm's reach before injecting — glucose tablets, juice, not something in a cupboard
  • Never inject before sleeping, and never when alone
  • Someone present who knows what was taken and can call emergency services
  • A glucose meter, used — not an estimate of how it feels
  • Know which insulin type is in the pen; rapid and long-acting are not interchangeable
  • No alcohol, which impairs the liver's ability to release glucose in response
  • Aware that beta blockers, including nebivolol, suppress the warning symptoms
  • Recognise the signs: sweating, trembling, racing heart, confusion, blurred vision, sudden hunger — treat immediately with carbohydrate, do not wait to see if it passes

If someone is unconscious or cannot swallow, that is an emergency call, not something to manage at home. Emergency staff need to know insulin was involved — it changes what they do.

Side Effects & Risks

  • Hypoglycaemia: confusion, seizures, unconsciousness, death
  • Permanent brain damage after a prolonged episode
  • Increased fat gain alongside muscle
  • Injection site reactions and fat tissue changes with repeated use
  • Water retention
  • With long-term use in non-diabetics: potential effect on the body's own insulin regulation
  • Warning symptoms masked by beta blockers

Blood Work & Monitoring

  • Blood glucose — measured with a meter, not estimated; the only relevant real-time value
  • HbA1c — for the longer-term picture
  • Fasting insulin and C-peptide — to assess the body's own production
  • Lipid profile (LDL, HDL, triglycerides)

Legal status by region

Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.

RegionRegulatory status
United StatesPrescription-only medicineApproved for diabetes. Use without a medical indication is off-label and unsupervised.
EU / UKPrescription-only medicine
Most other jurisdictionsPrescription-only; availability variesDispensed without prescription in some countries, which does not change the risk.
Competitive sportProhibited at all timesListed by WADA under S4.1 for athletes without diagnosed diabetes.
All content on this page is for information and harm-reduction purposes only. It is not medical advice, not a recommendation to purchase or use, and does not replace consulting a doctor. Legal status and enforcement vary by country and change; verifying the current rules in your own jurisdiction is your responsibility. For adults 18+ only. See the full disclaimer.